2-AMINO-6-N(t-BUTOXYCARBONYL)AMINO-1-HEXANOL | 191671-50-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-AMINO-6-N(t-BUTOXYCARBONYL)AMINO-1-HEXANOL
• 英文别名: tert-butyl N-(5-amino-6-hydroxyhexyl)carbamate
• CAS: 191671-50-8
• 化学式: C₁₁H₂₄N₂O₃
• 分子量: 232.323
• InChiKey: PKQRDACDTZZJTB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  16
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  84.6
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  aqueous THF 、 (S)-2-amino-6-(tert-butoxycarbonylamino)hexanoic acid 生成 2-AMINO-6-N(t-BUTOXYCARBONYL)AMINO-1-HEXANOL
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• LYSINE RELATED DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS
  申请人：Jonckers Tim Hugo Maria

  公开号：US20090118339A1

  公开（公告）日：2009-05-07

  The present invention concerns lysine related derivatives, their use as protease inhibitors, in particular as HIV aspartyl protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present lysine related derivatives with another anti retroviral agent. It further relates to their use in assays as reference compounds or as reagents.

  本发明涉及赖氨酸相关衍生物，它们作为蛋白酶抑制剂的用途，特别是作为HIV天冬氨酸蛋白酶抑制剂，它们的制备过程以及包含它们的制药组合物和诊断试剂盒。本发明还涉及本赖氨酸相关衍生物与另一种抗逆转录病毒药物的组合。它还涉及它们作为参考化合物或试剂在检测中的用途。
• Cycloalkane Carboxamide Derivatives and Production Process of Same
  申请人：Kobayashi Nobuo

  公开号：US20090156805A1

  公开（公告）日：2009-06-18

  Novel cycloalkane carboxamide derivatives having an action that selectively inhibits cathepsin K, and a production process thereof, are provided. A cycloalkane carboxamide derivative represented by the following general formula (I), or a pharmaceutically acceptable salt thereof: (wherein R 1 and R 2 represent (substituted) alkyl groups, (substituted) alkenyl groups, (substituted) alkynyl groups, (substituted) aromatic hydrocarbon groups or (substituted) heterocyclic groups, ring A represents an alkylidene group having 5 to 7 carbon atoms, and ring B represents a formyl group or a hydroxymethyl group).

  本发明提供了一种具有选择性抑制蛋白酶K的作用的新型环烷基羧酰胺衍生物及其生产工艺。其中，所述环烷基羧酰胺衍生物由下述通式（I）表示，或其药学上可接受的盐所表示（其中，R1和R2代表（取代）烷基、（取代）烯基、（取代）炔基、（取代）芳香族碳氢基或（取代）杂环基，环A表示具有5至7个碳原子的烷基亚基，环B表示甲酰基或羟甲基）。
• CYCLOALKANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING SAME
  申请人：SEIKAGAKU CORPORATION

  公开号：EP1972615A1

  公开（公告）日：2008-09-24

  Novel cycloalkane carboxamide derivatives having an action that selectively inhibits cathepsin K, and a production process thereof, are provided. A cycloalkane carboxamide derivative represented by the following general formula (I), or a pharmaceutically acceptable salt thereof: (wherein R1 and R2 represent (substituted) alkyl groups, (substituted) alkenyl groups, (substituted) alkynyl groups, (substituted) aromatic hydrocarbon groups or (substituted) heterocyclic groups, ring A represents an alkylidene group having 5 to 7 carbon atoms, and ring B represents a formyl group or a hydroxymethyl group).

  本发明提供了具有选择性抑制 cathepsin K 作用的新型环烷烃羧酰胺衍生物及其生产工艺。 由以下通式(I)代表的环烷烃羧酰胺衍生物或其药学上可接受的盐： (其中R1和R2代表（取代的）烷基、（取代的）烯基、（取代的）炔基、（取代的）芳香烃基团或（取代的）杂环基团，环A代表具有5至7个碳原子的亚烷基，环B代表甲酰基或羟甲基）。
• Macrocycles
  申请人：LUMIPHORE, INC.

  公开号：US10273256B2

  公开（公告）日：2019-04-30

  The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.

  本发明涉及可用于治疗和诊断的化合物和复合物。
• PREPARATION AND USE OF IMMUNOCONJUGATES
  申请人：Immunomedics, Inc.

  公开号：EP0732939A1

  公开（公告）日：1996-09-25